| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.1M | -37.8% | +111.4% |
| SG&A Expense | $1.8M | -0.1% | +58.8% |
| Operating Income | -$3.2M | +21.4% | -68.9% |
| Interest Expense | -$25K | +7.4% | +10.7% |
| Net Income | -$2.9M | +31.9% | -59.8% |
| EPS (Basic) | -$0.65 | +38.7% | -1200.0% |
| EPS (Diluted) | -$0.65 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.3M | +749.1% | +125.7% |
| Current Assets | $14.5M | +622.7% | +121.0% |
| Total Assets | $15.0M | +502.3% | +102.9% |
| Current Liabilities | $13.4M | +2.1% | +81.6% |
| Stockholders' Equity | -$13.5M | +46.4% | +23.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.9M | — | — |
| Financing Cash Flow | $13.5M | — | — |
| +38.7% |
| -1200.0% |